04 Mar 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Korea-based Dong-A Pharmaceutical has appointed Mr Lee Dong Hun as its new co-chief executive officer. He would be replacing Mr Kim Won Bae, effective March 4, 2013. The current co-CEO, Mr Kang Jeong Seok, will also continue his duty as co-CEO at the company.